USPTO 2015–2025 USPTO PatentsView US Corporation

West Pharmaceutical Services, Inc.

USPTO PatentsView assignee record - 110 granted patents across 33 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, West ranks #3,386 of 49,997 tracked US assignees by granted-patent volume, with 110 patents across 33 technology areas.

#3,386
of 49,997 US assignees by volume
Top 18%
by Innovation Score (47.6/100)
10.4
avg claims per patent
-5%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3386 · US Corporation #3,386 · 110 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-MID 110 grants
  • TOP-DECILE #3,386/49,997
  • PHOTO-FINISH Shanghai Micro…
  • CPC-FOCUS A61M · 33 areas
  • INNOV-PAR 47.6/100
  • CLAIMS-PAR 10.4 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-FLAT -5% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Shanghai Micro Electronics Equipment (GROUP) Co., Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around West

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows West's Innovation Score is 47.6/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where West's grants concentrate

West Pharmaceutical Services, Inc. is a focused PatentsView assignee: 33 CPC subclasses with 48.2% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2019 (20 grants) versus a trough of 4 in 2015. By volume, West sits between Shanghai Micro Electronics Equipment (GROUP) Co., Ltd and Bitzer Kühlmaschinenbau GmbH.

West's three-year grant acceleration

From 2019–2021 to 2022–2024, West Pharmaceutical Services, Inc. moved from 42 to 30 grants (0.71x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,108. See the growth leaderboard.

Who files at West's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows West holds 110 patents at rank #3,386, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near West

By rank, the assignees closest to #3,386 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in West's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for West, neither rank-band nor same-CPC leaders (those blocks stay above).

West's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0510152025 20152016201720182019202020212022202320242025 3
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
West Pharmaceutical Services, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 3.6%
2016 7 6.4%
2017 14 12.7%
2018 10 9.1%
2019 20 18.2%
2020 9 8.2%
2021 13 11.8%
2022 10 9.1%
2023 11 10.0%
2024 9 8.2%
2025partial year 3 2.7%

Which technologies does West Pharmaceutical Services, Inc. patent most?

Top 15 of 33 technology areas

Where it ranks

Overall rank by patents

#3,386

of 49,997 tracked assignees

Innovation Score

47.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

West Pharmaceutical Services, Inc.'s patent record in context - here's where to go next.

  • West Pharmaceutical Services, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 48.2% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #3,386 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare West Pharmaceutical Services, Inc. against Shanghai Micro Electronics Equipment (GROUP) Co., Ltd, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 47.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.